AGILE THERAPEUTICS INC (AGRX)

US00847L3087 - Common Stock

0.6022  +0.06 (+10.11%)

After market: 0.2408 -0.36 (-60.01%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
19.97M10.88M4.10M750.00K0.00
Cost Of Goods
8.44M6.84M10.72M280.00KN/A
Gross Profit
11.54M4.05M-6.62M470.00KN/A
Operating Expenses
34.24M45.48M64.39M49.52M18.86M
Research and Development
2.52M3.25M6.25M13.50M9.86M
Selling, General, and Administrative Expenses
31.73M42.23M58.14M36.02M9.00M
Operating Income
-22.72M-41.44M-71.01M-49.05M-18.86M
Interest Income/Expense
30.96M22.47M-60.00K-2.80M250.00K
Non Recurring Items
N/A-11.12MN/A0.000.00
Income Before Taxes
8.24M-30.09M-71.07M-51.85M-18.61M
Income Tax
0.00-4.68M0.000.000.00
Net Income
8.24M-25.41M-71.07M-51.85M-18.61M
EBITDA
-22.34M-39.91M-68.79M-48.77M-18.70M
 
Per Share Data
EPS Diluted Total Ops
13.64-59.09-1.42K-1.30K-930.50
Non GAAP EPS
-13.33N/A-423.20-24.00-15.60
 
Statistics
Gross Profit Margin
57.79%37.22%-161.46%62.67%N/A
Profit Margin
41.26%-233.55%-1733.41%-6913.33%N/A
Operating Profit Margin
-113.77%-380.88%-1731.95%-6540.00%N/A

All data in USD

Charts